Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 8Carcinoma, Basal Cell 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Skin Neoplasms 2Ovarian Neoplasms 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2Uveal Melanoma 1Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Spondylitis, Ankylosing 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Psoriasis 1Pancreatic Neoplasms 1Myelodysplastic Syndromes 1Lupus Erythematosus, Systemic 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Inflammatory Bowel Diseases 1Dysplastic Nevus Syndrome 1Disease Progression 1Crohn Disease 1Colonic Neoplasms 1Colitis, Ulcerative 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

pembrolizumab 1Standard of Care 1Practice Guidelines as Topic 1Nivolumab 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colitis, Ulcerative × Standard of Care × Dermatologic × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡